Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00383201
Recruitment Status : Completed
First Posted : October 2, 2006
Last Update Posted : August 16, 2012
Information provided by (Responsible Party):
Alcon Research

Brief Summary:
To clinically evaluate the effect of a new multi-purpose disinfecting solution compared to a marketed multi-purpose solution on wettability of soft contact lenses worn for 30 days.

Condition or disease Intervention/treatment
Contact Lens Care Device: OptiFree Multi-Purpose Disinfecting Solution

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 80 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double
Primary Purpose: Treatment
Official Title: Long-Term Effect of Multi-Purpose Solutions on Ex-Vivo Wetting Angles of Soft Contact Lenses
Study Start Date : March 2005
Primary Completion Date : September 2005
Study Completion Date : September 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Eye Wear
U.S. FDA Resources

Primary Outcome Measures :
  1. Efficacy:
  2. Contact lens wetting angle measured ex-vivo
  3. Safety:
  4. Slit-lamp Findings: Eyelids and Conjunctiva; Cornea; Iris, Anterior Chamber
  5. Visual Acuity (Snellen)
  6. Adverse Events

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
  • Successful daily wear of FDA Group I or IV soft contact lenses for at least one week.
  • Vision correctable to 20/30.
  • Normal eyes - no current ocular abnormalities that prevent successful contact lens wear.
  • No corneal surgery within the past 12 months.
  • No systemic disease that affects that eye or that could be worsened by the use of contact lenses or solutions.
  • No over-the-counter or prescription ocular medication.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00383201

United States, Texas
Fort Worth Site
Fort Worth, Texas, United States, 76134
Sponsors and Collaborators
Alcon Research
Study Director: Leslie Napier Alcon Research

Responsible Party: Alcon Research Identifier: NCT00383201     History of Changes
Other Study ID Numbers: C-05-01
First Posted: October 2, 2006    Key Record Dates
Last Update Posted: August 16, 2012
Last Verified: September 2006

Keywords provided by Alcon Research:
Contact Lens Care

Additional relevant MeSH terms:
Pharmaceutical Solutions